Pelthos Therapeutics Inc. (CHRO)
Jul 2, 2025 - CHRO was delisted (reason: merged into PTHS)
13.50
0.00 (0.00%)
Inactive · Last trade price
on Jul 1, 2025
Channel Therapeutics Employees
As of December 31, 2024, Pelthos Therapeutics had 11 total employees, including 4 full-time and 7 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$1,129,742
Market Cap
100.88M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11 | 3 | 37.50% |
| Dec 31, 2023 | 8 | 6 | 300.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | - | - |
CHRO News
- 7 weeks ago - Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics - Business Wire
- 7 weeks ago - Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance - GlobeNewsWire
- 2 months ago - Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice - GlobeNewsWire
- 3 months ago - Pelthos Pharmaceuticals: Off To A Strong Start With Zelsuvmi, Continued Sales Growth Is Likely - Seeking Alpha
- 4 months ago - Pelthos Therapeutics Inc. (PTHS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 4 months ago - Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing - GlobeNewsWire
- 4 months ago - Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025 - GlobeNewsWire